Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.72    0.48 (1.40%)
Bid:
34.80
Ask:
35.52
Spread: 0.72 (2.069%)
Market Cap: £555.18m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Share Buyback Programme

24 Feb 2023 07:00

RNS Number : 8971Q
Hays PLC
24 February 2023
 

 

FOR IMMEDIATE RELEASE

 

24 February 2023

Hays plc

Share Buyback Programme

On 20 June 2022, Hays plc (the "Company") announced that it had entered into a non-discretionary arrangement with Jefferies International Limited ("Jefferies") in relation to the programme to repurchase the Company's ordinary 1 pence shares up to the value of c.£63million.

In the six months ending 31 December 2022, 50.2million shares were purchased and cancelled, at a cost of £57.6million. On 23 February 2023, the Company entered into a further agreement with Jefferies in relation to the purchase by Jefferies of ordinary shares up to the value of £18,200,000. The programme will be executed by Jefferies from the date of this announcement and will end no later than 30 June 2023.

As announced on 28 April 2022, the purpose of the programme is to reduce the total issued share capital of the Company. Jefferies will purchase the Company's ordinary shares as principal and sell them on to the Company in accordance with the terms of their engagement. The Company intends to cancel the shares it purchases through the programme.

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Jefferies engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's annual general meeting held on 9 November 2022 (which permits the Company to purchase no more than 162,523,118 of the Company's ordinary shares, taking into account the amount of shares already repurchased using this authority under the buyback programmes announced on 23 September 2020, 29 November 2021 and 28 April 2022), the EU Market Abuse Regulation (596/2014) as it applies in the UK, the Commission Delegated Regulation (2016/1052) as it applies in the UK and Chapter 12 of the Financial Conduct Authority's Listing Rules.

 

For further information please contact:

David Phillips, Head of Investor Relations and ESG on +44 (0) 333 010 7122, or ir@hays.com

LEI code: 213800QC8AWD4BO8TH08

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKNBBPBKDKBB
Date   Source Headline
25th Sep 20253:54 pmRNSDirector/PDMR Shareholding
18th Sep 20251:29 pmRNSDirector/PDMR Shareholding
15th Sep 20254:50 pmRNSDirector/PDMR Shareholding
5th Sep 20252:52 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:00 pmRNSDirector/PDMR Shareholding
1st Sep 202510:00 amRNSTotal Voting Rights
29th Aug 202512:59 pmRNSDirector/PDMR Shareholding
27th Aug 202512:32 pmRNSDirector/PDMR Shareholding
26th Aug 20253:43 pmRNSDirector/PDMR Shareholding
22nd Aug 20253:00 pmRNSDirector/PDMR Shareholding
21st Aug 20254:30 pmRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSPreliminary Report 2025
4th Aug 20254:21 pmRNSTotal Voting Rights
1st Aug 202510:00 amRNSBlock listing Interim Review
23rd Jul 202510:38 amRNSHolding(s) in Company
14th Jul 20255:19 pmRNSHolding(s) in Company
11th Jul 20251:00 pmRNSAppointment of Joint Corporate Broker
4th Jul 20252:43 pmRNSBoard Committee membership changes
1st Jul 202510:00 amRNSTotal Voting Rights
24th Jun 20257:00 amRNSHolding(s) in Company
20th Jun 20259:37 amRNSDirector/PDMR Shareholding
19th Jun 202510:18 amRNSHolding(s) in Company
19th Jun 20257:00 amRNSPre-Close Year End Trading Update
4th Jun 20251:40 pmRNSHolding(s) in Company
3rd Jun 20255:54 pmRNSDirector/PDMR Shareholding
2nd Jun 202510:00 amRNSTotal Voting Rights
29th May 20253:46 pmRNSHolding(s) in Company
20th May 20254:55 pmRNSResponse to Voting Results at 2024 AGM
9th May 20252:24 pmRNSOutcome of Audit Tender Process
1st May 202510:00 amRNSTotal Voting Rights
16th Apr 20254:22 pmRNSDirector/PDMR Shareholding
16th Apr 20257:00 amRNSThird Quarter Trading Statement
15th Apr 20255:15 pmRNSDirector/PDMR Shareholding
10th Apr 20254:10 pmRNSDirector/PDMR Shareholding
1st Apr 202510:00 amRNSTotal Voting Rights
27th Mar 202512:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202510:00 amRNSTotal Voting Rights
25th Feb 20252:30 pmRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSHalf Year Report
3rd Feb 202510:15 amRNSBlock listing Interim Review
3rd Feb 202510:00 amRNSTotal Voting Rights
16th Jan 20257:00 amRNSBoard Changes
15th Jan 20257:00 amRNSSecond Quarter Trading Statement
13th Jan 20252:14 pmRNSDirector Declaration
2nd Jan 202510:50 amRNSHolding(s) in Company
2nd Jan 202510:35 amRNSTotal Voting Rights
17th Dec 20241:00 pmRNSDirector/PDMR Shareholding
16th Dec 20249:17 amRNSDirector/PDMR Shareholding
9th Dec 20242:37 pmRNSDB pension scheme de-risked with full buy-in
2nd Dec 202411:55 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.